Dyadic International (DYAI) 1.0100 $DYAI
Dyadic International to Present at the 4th International Conference on Biologics and Biosimilars
GlobeNewswire - Thu Oct 08, 3:30PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX
YAI) announced that Dyadic's Chief Executive Officer Mark Emalfarb will make a presentation titled "There's a saying that expression systems aren't everything, but everything is nothing without a good expression system" at the 4 International Conference on Biologics and Biosimilars on Monday, October 26, 2015 at 4:30 p.m. ET at the DoubleTree by Hilton Hotel Baltimore - BWI Airport - Linthicum, Maryland.
Dyadic Receives C1 Derived Vaccine Test Results From Sanofi Pasteur and Provides Further Details on New EU-Funded ZAPI Biopharmaceutical Program
GlobeNewswire - Wed Oct 07, 10:13AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX YAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the biopharmaceutical, bioenergy, bio-based chemicals, food and feed industries, announced today it has received the test results from the mice trials in our research program with Sanofi Pasteur. The data generated by Sanofi Pasteur indicates that the C1 produced antigen generated an equal, or better, immune response in mice than the industry standard antigen.
Industrial Enzymes (Carbohydrases, Proteases, Non-starch Polysaccharides & Others) Market 2015 - Global Trends and Forecasts to 2020
M2 - Fri Sep 18, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9hhnmw/industrial) has announced the addition of the "Industrial Enzymes Market by Type, Application, Brands & by Region - Global Trends and Forecasts to 2020" report to their offering. The industrial enzymes market is growing with increase in the applications of industrial enzymes. The industrial enzymes market was valued at USD 4.2 billion in 2014 and is projected to reach USD 6.2 billion by 2020, at a CAGR of 7.0% from 2015 to 2020. The market is driven by factors such as increase in investments in research and developments in industrial enzymes, the increase in demand of consumer goods and biofuels, and the need for cost reduction and resource optimization in production process. Industrial enzymes are used as an alternative of synthetic chemicals. The innovations in technology and increase in the applications provides opportunities for emerging market players. The food & beverage segment dominated the industrial enzymes market and is projected to reach a value of USD 2.0 billion by 2020. It is projected to grow at the rate of around 7.5% between 2015 and 2020. By type, the carbohydrases segment dominated the market and is projected to grow at the highest CAGR of 7.5% from 2015 to 2020. The key market players adopt strategies such as new product developments, expansions, acquisitions, partnerships, and collaborations to develop their position in the industrial enzymes market. The Asia-Pacific region is projected to grow at the highest CAGR from 2015 to 2020. The increase in disposable incomes and change in lifestyle of the population in the Asia-Pacific region has resulted in an increase in the demand of consumer goods which has resulted the growth of the industrial enzymes market in this region. The industrial enzymes market is segmented on the basis of applications. The applications considered for the research are food & beverage, cleaning agents, animal feed, and others that include textile & leather, water treatment, and pulp & paper among others. The types of industrial enzymes which are used to manufacture enzymes for various applications are also classified in the report. T he key players in this market are BASF SE (Germany), E.I. du Pont de Nemours and Company (U.S.), Associated British Foods plc (U.K.), Koninklijke DSM N.V (The Netherlands), and Novozymes A/S (Germany). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Industrial Enzymes Market, by Type 8 Industrial Enzymes Market, by Brand 9 Industrial Enzymes Market, by Application 10 Industrial Enzymes Market, by Region 11 Competitive Landscape 12 Company Profiles - Basf Se - E. I. Du Pont De Nemours and Company - Associated British Foods Plc - Koninklijke Dsm N.V - Novozymes A/S - Adisseo France Sas - Chr. Hansen A/S - Codexis Incorporated - Dyadic International Incorporated - Amano Enzyme Incorporated For more information visit http://www.researchandmarkets.com/research/9hhnmw/industrial
CDXS: 3.55 (+0.06)
Dyadic International Reports Second Quarter 2015 Financial Results
GlobeNewswire - Fri Aug 14, 3:30PM CDT
-- First Half Revenue Up 30% Year-Over-Year
Dyadic International Announces It Has Reached a Settlement With One of the Three Remaining Defendant Law Firms in Its Professional Liability Litigation
GlobeNewswire - Wed Aug 05, 3:32PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX YAI), today announced it has reached a settlement with one of the three remaining defendant law firms in its ongoing professional liability litigation.
Dyadic International to Announce Second Quarter 2015 Financial Results on Friday August 14, 2015 and Host Conference Call on Monday, August 17, 2015
GlobeNewswire - Wed Aug 05, 3:30PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX YAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for quarter ending June 30, 2015 after market close on Friday August 14, 2015 and will host a conference call on Monday August 17, 2015 at 5:00 p.m. Eastern Time to discuss those results.
Global Industrial Enzymes Market 2015-2019 with Amano Enzyme, Codexis, DSM, Dupont Danisco, Dyadic International & Novozymes Dominating
PR Newswire Europe - Wed Jun 24, 11:12AM CDT
DUBLIN, June 23, 2015 /PRNewswire/ --
Dyadic International's (DYAI) CEO Mark Emalfarb Discusses on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 8:31PM CDT
Dyadic International Reports First Quarter 2015 Financial Results
GlobeNewswire - Thu May 14, 3:30PM CDT
-- Total Revenue up 35% Year-over-Year
Dyadic Receives Funding for New Advanced Biofuels Program
PR Newswire - Wed May 13, 3:15PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding 2G BIOPIC, a new advanced biofuels project funded by the European Commission's Horizon 2020 program. In the 2G BIOPIC project, Dyadic's subsidiary Dyadic Netherlands B.V. ("Dyadic Netherlands" will work in collaboration with Compagnie Industrielle de Matiere Vegetale ("CIMV" and five other industry partners to develop, construct and operate a large demonstration-scale facility that produces ethanol from biomass.
Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015
PR Newswire - Mon May 04, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for quarter ending March 31, 2015 after market close on Thursday, May 14, 2015 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results.
Dyadic International Receives Two Additional Research Milestone Payments From BASF
PR Newswire - Tue Apr 28, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company with patented and proprietary technologies used to develop and produce enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, today announced the receipt of $800,000 for achieving two additional research and development milestones in its funded research program with BASF, a Dyadic C1 Technology licensee.
Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors
PR Newswire - Wed Mar 18, 3:15PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI) today announced the appointment of Jack Kaye to the Board of Directors, effective April 1, 2015. Mr. Kaye will serve on the audit and compensation committees. With the addition of Mr. Kaye, there will be seven members on the Dyadic Board.
KERX: 4.25 (+0.23)
Dyadic International's (DYAI) CEO Mark Emalfarb on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 11, 8:18PM CDT
Dyadic International Reports 2014 Year End Financial Results
PR Newswire - Wed Mar 11, 3:15PM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced today announced financial results for the year ended December 31, 2014.
Global Biocatalysis & Biocatalysts Market Report 2015-2019 with Novozymes, DuPont & DSM Featuring as the Most Active Players
M2 - Wed Mar 11, 7:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fxtvw4/biocatalysis_and) has announced the addition of the "Biocatalysis & Biocatalysts Market By Type (Hydrolases, Oxidoreductases, Transferases, And Others), Application (Food & Beverages, Cleaning Agents, Agriculture & Feed, Biofuel Production, Biopharmaceuticals, And Others), and Geography - Forecast to 2019 " report to their offering. The biocatalysts market was estimated around 81 kilo tons in 2013, with the high share of around 70% held by North America and Europe together. The global biocatalysts market by volume is projected to grow at a CAGR of 5.5% from 2014 to 2019. The high growth is forecasted to be in the RoW due to rise of end industries such as biofuel production, agriculture & feed, food and beverages in the region. Europe is estimated to have the second highest growth around 6.71% from 2014 to 2019. Advancements in the biocatalysis process have led to increased penetration of biocatalysts in different applications. Biofuel and detergent industries have the largest application of biocatalysts. Food & beverages, agriculture & feed, biopharmaceuticals are the other significant applications. Small applications include life science applications, textile, leather, pulp & paper, and flavor & fragrances. Biofuel and biopharmaceuticals applications are predicted to show the highest growth rate in the next five years. Hydrolases, transferases, and oxidoreductases are the major types of biocatalysts. The other three segments of biocatalysts lyases, isomerases, and ligases are small part of the biocatalysts market currently. The biocatalysts market is anticipated to show a high growth rate in the coming years. The market is innovation driven and investments are expected for new biocatalysis process and enzyme development. There are large numbers of various sized players in the market but it is dominated by few big companies. Currently, the biocatalyst market is mainly concentrated in the North American and European region while RoW region, especially Latin America is expected to show high growth rate in future years. Advancement in biocatalysis process along with increasing penetration of biocatalysts in different applications is driving the growth of the global biocatalysts market. Novozymes (Denmark), DuPont (U.S.), DSM (Netherlands) are the important active players in the biocatalysts market. These companies showed the highest strategy adoptions amongst other players in the biocatalysts market from 2010 to 2014. These companies together hold around 70% share of the biocatalysts market. From 2010 to 2014, partnership, agreement, and collaboration was observed as the most important growth strategy adopted by the major biocatalysts, accounting for a share of more than 50% of the total strategies adopted by the players. The other companies AB Enzymes (Germany), Codexis Inc. (U.S.), and BASF (Germany) also contributed to the market activities in the global biocatalysts market during the above mentioned period. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Biocatalysis And Biocatalysts Market, By Type 8 Biocatalysis And Biocatalysts Market, By Application 9 Regional Analysis 10 Competitive Landscape 11 Company Profiles - Ab Enzymes Gmbh - Amano Enzymes - Basf Se - Chr. Hansen - Codexis Inc. - Dyadic International - E.I. Dupont De Nemours & Co. - Novozymes A/S - Royal Dsm N.V. - Soufflet Group For more information visit http://www.researchandmarkets.com/research/fx...alysis_and
CDXS: 3.55 (+0.06)
Dyadic International Raises $2 Million In Private Placement Of Convertible Note
PR Newswire - Mon Mar 09, 7:30AM CDT
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced that it has completed a private placement of $2,000,000 in convertible subordinated secured promissory note (the "Note" .
Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors
PR Newswire - Mon Jan 12, 7:40AM CST
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today the appointment of Michael Tarnok as the company's Chairman of the Board of Directors. Mr. Tarnok will continue to serve on the company's audit and compensation committees.
KERX: 4.25 (+0.23)
Dyadic International Extends Debt Maturity Date On Note Payable
PR Newswire - Mon Jan 05, 3:15PM CST
Dyadic International, Inc. ("Dyadic" (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into an agreement to extend the maturity date of the $1.4 million non-convertible 9.5% note payable (the "Debt" to January 1, 2016. All other terms and conditions of the Debt remain unchanged.
Dyadic International to Present at the 4th International Conference on Biologics and Biosimilars
GlobeNewswire - Thu Oct 08, 3:30PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX YAI) announced that Dyadic's Chief Executive Officer Mark Emalfarb will make a presentation titled "There's a saying that expression systems aren't everything, but everything is nothing without a good expression system" at the 4 International Conference on Biologics and Biosimilars on Monday, October 26, 2015 at 4:30 p.m. ET at the DoubleTree by Hilton Hotel Baltimore - BWI Airport - Linthicum, Maryland. Dyadic Receives C1 Derived Vaccine Test Results From Sanofi Pasteur and Provides Further Details on New EU-Funded ZAPI Biopharmaceutical Program
GlobeNewswire - Wed Oct 07, 10:13AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX YAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the biopharmaceutical, bioenergy, bio-based chemicals, food and feed industries, announced today it has received the test results from the mice trials in our research program with Sanofi Pasteur. The data generated by Sanofi Pasteur indicates that the C1 produced antigen generated an equal, or better, immune response in mice than the industry standard antigen. Industrial Enzymes (Carbohydrases, Proteases, Non-starch Polysaccharides & Others) Market 2015 - Global Trends and Forecasts to 2020
M2 - Fri Sep 18, 6:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9hhnmw/industrial) has announced the addition of the "Industrial Enzymes Market by Type, Application, Brands & by Region - Global Trends and Forecasts to 2020" report to their offering. The industrial enzymes market is growing with increase in the applications of industrial enzymes. The industrial enzymes market was valued at USD 4.2 billion in 2014 and is projected to reach USD 6.2 billion by 2020, at a CAGR of 7.0% from 2015 to 2020. The market is driven by factors such as increase in investments in research and developments in industrial enzymes, the increase in demand of consumer goods and biofuels, and the need for cost reduction and resource optimization in production process. Industrial enzymes are used as an alternative of synthetic chemicals. The innovations in technology and increase in the applications provides opportunities for emerging market players. The food & beverage segment dominated the industrial enzymes market and is projected to reach a value of USD 2.0 billion by 2020. It is projected to grow at the rate of around 7.5% between 2015 and 2020. By type, the carbohydrases segment dominated the market and is projected to grow at the highest CAGR of 7.5% from 2015 to 2020. The key market players adopt strategies such as new product developments, expansions, acquisitions, partnerships, and collaborations to develop their position in the industrial enzymes market. The Asia-Pacific region is projected to grow at the highest CAGR from 2015 to 2020. The increase in disposable incomes and change in lifestyle of the population in the Asia-Pacific region has resulted in an increase in the demand of consumer goods which has resulted the growth of the industrial enzymes market in this region. The industrial enzymes market is segmented on the basis of applications. The applications considered for the research are food & beverage, cleaning agents, animal feed, and others that include textile & leather, water treatment, and pulp & paper among others. The types of industrial enzymes which are used to manufacture enzymes for various applications are also classified in the report. T he key players in this market are BASF SE (Germany), E.I. du Pont de Nemours and Company (U.S.), Associated British Foods plc (U.K.), Koninklijke DSM N.V (The Netherlands), and Novozymes A/S (Germany). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Industrial Enzymes Market, by Type 8 Industrial Enzymes Market, by Brand 9 Industrial Enzymes Market, by Application 10 Industrial Enzymes Market, by Region 11 Competitive Landscape 12 Company Profiles - Basf Se - E. I. Du Pont De Nemours and Company - Associated British Foods Plc - Koninklijke Dsm N.V - Novozymes A/S - Adisseo France Sas - Chr. Hansen A/S - Codexis Incorporated - Dyadic International Incorporated - Amano Enzyme Incorporated For more information visit http://www.researchandmarkets.com/research/9hhnmw/industrial
CDXS: 3.55 (+0.06)
Dyadic International Reports Second Quarter 2015 Financial Results
GlobeNewswire - Fri Aug 14, 3:30PM CDT
-- First Half Revenue Up 30% Year-Over-Year
Dyadic International Announces It Has Reached a Settlement With One of the Three Remaining Defendant Law Firms in Its Professional Liability Litigation
GlobeNewswire - Wed Aug 05, 3:32PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX YAI), today announced it has reached a settlement with one of the three remaining defendant law firms in its ongoing professional liability litigation. Dyadic International to Announce Second Quarter 2015 Financial Results on Friday August 14, 2015 and Host Conference Call on Monday, August 17, 2015
GlobeNewswire - Wed Aug 05, 3:30PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX YAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for quarter ending June 30, 2015 after market close on Friday August 14, 2015 and will host a conference call on Monday August 17, 2015 at 5:00 p.m. Eastern Time to discuss those results. Global Industrial Enzymes Market 2015-2019 with Amano Enzyme, Codexis, DSM, Dupont Danisco, Dyadic International & Novozymes Dominating
PR Newswire Europe - Wed Jun 24, 11:12AM CDT
DUBLIN, June 23, 2015 /PRNewswire/ --
Dyadic International's (DYAI) CEO Mark Emalfarb Discusses on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 8:31PM CDT
Dyadic International Reports First Quarter 2015 Financial Results
GlobeNewswire - Thu May 14, 3:30PM CDT
-- Total Revenue up 35% Year-over-Year
Dyadic Receives Funding for New Advanced Biofuels Program
PR Newswire - Wed May 13, 3:15PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding 2G BIOPIC, a new advanced biofuels project funded by the European Commission's Horizon 2020 program. In the 2G BIOPIC project, Dyadic's subsidiary Dyadic Netherlands B.V. ("Dyadic Netherlands" will work in collaboration with Compagnie Industrielle de Matiere Vegetale ("CIMV" and five other industry partners to develop, construct and operate a large demonstration-scale facility that produces ethanol from biomass. Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015
PR Newswire - Mon May 04, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it will report its financial results for quarter ending March 31, 2015 after market close on Thursday, May 14, 2015 and will host a conference call that day at 5:00 p.m. Eastern Time to discuss those results. Dyadic International Receives Two Additional Research Milestone Payments From BASF
PR Newswire - Tue Apr 28, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company with patented and proprietary technologies used to develop and produce enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals, and industrial enzymes industries, today announced the receipt of $800,000 for achieving two additional research and development milestones in its funded research program with BASF, a Dyadic C1 Technology licensee. Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors
PR Newswire - Wed Mar 18, 3:15PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI) today announced the appointment of Jack Kaye to the Board of Directors, effective April 1, 2015. Mr. Kaye will serve on the audit and compensation committees. With the addition of Mr. Kaye, there will be seven members on the Dyadic Board. KERX: 4.25 (+0.23)
Dyadic International's (DYAI) CEO Mark Emalfarb on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 11, 8:18PM CDT
Dyadic International Reports 2014 Year End Financial Results
PR Newswire - Wed Mar 11, 3:15PM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced today announced financial results for the year ended December 31, 2014. Global Biocatalysis & Biocatalysts Market Report 2015-2019 with Novozymes, DuPont & DSM Featuring as the Most Active Players
M2 - Wed Mar 11, 7:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fxtvw4/biocatalysis_and) has announced the addition of the "Biocatalysis & Biocatalysts Market By Type (Hydrolases, Oxidoreductases, Transferases, And Others), Application (Food & Beverages, Cleaning Agents, Agriculture & Feed, Biofuel Production, Biopharmaceuticals, And Others), and Geography - Forecast to 2019 " report to their offering. The biocatalysts market was estimated around 81 kilo tons in 2013, with the high share of around 70% held by North America and Europe together. The global biocatalysts market by volume is projected to grow at a CAGR of 5.5% from 2014 to 2019. The high growth is forecasted to be in the RoW due to rise of end industries such as biofuel production, agriculture & feed, food and beverages in the region. Europe is estimated to have the second highest growth around 6.71% from 2014 to 2019. Advancements in the biocatalysis process have led to increased penetration of biocatalysts in different applications. Biofuel and detergent industries have the largest application of biocatalysts. Food & beverages, agriculture & feed, biopharmaceuticals are the other significant applications. Small applications include life science applications, textile, leather, pulp & paper, and flavor & fragrances. Biofuel and biopharmaceuticals applications are predicted to show the highest growth rate in the next five years. Hydrolases, transferases, and oxidoreductases are the major types of biocatalysts. The other three segments of biocatalysts lyases, isomerases, and ligases are small part of the biocatalysts market currently. The biocatalysts market is anticipated to show a high growth rate in the coming years. The market is innovation driven and investments are expected for new biocatalysis process and enzyme development. There are large numbers of various sized players in the market but it is dominated by few big companies. Currently, the biocatalyst market is mainly concentrated in the North American and European region while RoW region, especially Latin America is expected to show high growth rate in future years. Advancement in biocatalysis process along with increasing penetration of biocatalysts in different applications is driving the growth of the global biocatalysts market. Novozymes (Denmark), DuPont (U.S.), DSM (Netherlands) are the important active players in the biocatalysts market. These companies showed the highest strategy adoptions amongst other players in the biocatalysts market from 2010 to 2014. These companies together hold around 70% share of the biocatalysts market. From 2010 to 2014, partnership, agreement, and collaboration was observed as the most important growth strategy adopted by the major biocatalysts, accounting for a share of more than 50% of the total strategies adopted by the players. The other companies AB Enzymes (Germany), Codexis Inc. (U.S.), and BASF (Germany) also contributed to the market activities in the global biocatalysts market during the above mentioned period. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Biocatalysis And Biocatalysts Market, By Type 8 Biocatalysis And Biocatalysts Market, By Application 9 Regional Analysis 10 Competitive Landscape 11 Company Profiles - Ab Enzymes Gmbh - Amano Enzymes - Basf Se - Chr. Hansen - Codexis Inc. - Dyadic International - E.I. Dupont De Nemours & Co. - Novozymes A/S - Royal Dsm N.V. - Soufflet Group For more information visit http://www.researchandmarkets.com/research/fx...alysis_and
CDXS: 3.55 (+0.06)
Dyadic International Raises $2 Million In Private Placement Of Convertible Note
PR Newswire - Mon Mar 09, 7:30AM CDT
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced that it has completed a private placement of $2,000,000 in convertible subordinated secured promissory note (the "Note" . Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors
PR Newswire - Mon Jan 12, 7:40AM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins, announced today the appointment of Michael Tarnok as the company's Chairman of the Board of Directors. Mr. Tarnok will continue to serve on the company's audit and compensation committees. KERX: 4.25 (+0.23)
Dyadic International Extends Debt Maturity Date On Note Payable
PR Newswire - Mon Jan 05, 3:15PM CST
Dyadic International, Inc. ("Dyadic"
(OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has entered into an agreement to extend the maturity date of the $1.4 million non-convertible 9.5% note payable (the "Debt" to January 1, 2016. All other terms and conditions of the Debt remain unchanged. 
